Results 21 to 30 of about 2,200,984 (302)

Cyclodextrin-based nanosponges as drug carriers

open access: yesBeilstein Journal of Organic Chemistry, 2012
Cyclodextrin-based nanosponges, which are proposed as a new nanosized delivery system, are innovative cross-linked cyclodextrin polymers nanostructured within a three-dimensional network.
Francesco Trotta   +2 more
doaj   +1 more source

Vesicular Carriers for Follicular Drug Delivery [PDF]

open access: yesPharmaceutical Sciences
The follicular route has been explored for both topical and systemic drug delivery but its application is challenged by different limitations such as sebum flow and size-selectivity.
Mostafa Amirinejad   +3 more
doaj   +1 more source

Composing On-Program Triggers and On-Demand Stimuli into Biosensor Drug Carriers in Drug Delivery Systems for Programmable Arthritis Therapy

open access: yesPharmaceuticals, 2022
Medication in arthritis therapies is complex because the inflammatory progression of rheumatoid arthritis (RA) and osteoarthritis (OA) is intertwined and influenced by one another. To address this problem, drug delivery systems (DDS) are composed of four
Yan Yik Lim   +2 more
doaj   +1 more source

Why nanodiamond carriers manage to overcome drug resistance in cancer [PDF]

open access: yes, 2020
Nanodiamonds represent an attractive potential carrier for anticancer drugs. The main advantages of nanodiamond particles with respect to medical applications are their high compatibility with non-cancerous cells, feasible surface decoration with ...
Benson, Veronika   +2 more
core   +1 more source

Preparation of amphiphilic magnetic polyvinyl alcohol targeted drug carrier and drug delivery research

open access: yesDesigned Monomers and Polymers, 2020
Currently, magnetic applications have great potential for development in the field of drug carriers. In this paper, Fe3O4-PVA@SH, an amphiphilic magnetically targeting drug carrier, was prepared by using Fe3O4 and PVA with thiohydrazide ...
Yazhen Wang   +6 more
doaj   +1 more source

Star-shaped poly(ε-caprolactones) with well-defined architecture as potential drug carriers [PDF]

open access: yesJournal of the Serbian Chemical Society, 2022
The present study reports the potential application of star-shaped poly(ε-caprolactones) with different number of arms as new drug delivery matrix. Linear and star-shaped PCL ibuprofen loaded microspheres were prepared using oil-in-water (o/w) solvent ...
Ponjavić Marijana   +5 more
doaj   +1 more source

Aptamers as Both Drugs and Drug-Carriers [PDF]

open access: yesBioMed Research International, 2014
Aptamers are short nucleic acid oligos. They may serve as both drugs and drug-carriers. Their use as diagnostic tools is also evident. They can be generated using various experimental, theoretical, and computational techniques. The systematic evolution of ligands by exponential enrichment which uses iterative screening of nucleic acid libraries is a ...
openaire   +2 more sources

Alkylcyanoacrylate drug carriers: I. Physicochemical characterization of nanoparticles with different alkyl chain length [PDF]

open access: yes, 1992
Alkylcyanoacrylate particles were physico-chemically characterized in terms of size, surface charge, zeta potential, interaction with charged serum components and surface hydrophobicity as relevant parameters influencing the in vitro interaction with ...
Müller, R. H.   +4 more
core   +1 more source

Chitosan Contribution to Therapeutic and Vaccinal Approaches for the Control of Leishmaniasis

open access: yesMolecules, 2020
The control of leishmaniases, a complex parasitic disease caused by the protozoan parasite Leishmania, requires continuous innovation at the therapeutic and vaccination levels.
Philippe M. Loiseau   +2 more
doaj   +1 more source

Solid Lipid Nanoparticles: A Potential Approach for Dermal Drug Delivery [PDF]

open access: yes, 2014
Solid lipid nanoparticles (SLNs) have attracted increasing attention during recent years. Due to their unique size dependent properties, lipid nanoparticles offer possibilities to develop new therapeutics.
Conway, Barbara R   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy